EicOsis Human Health Inc.
EicOsis Human Health Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Renal Impairment Study for Oral EC5026 | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-07-10 | NCT07694544 | |
| Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) | Parkinson's Disease (PD) | Recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT07142044 | |
| Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, central nervous system disorder, injury, intervertebral disk degenerative disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, neuralgia, neuromuscular disease, peripheral nervous system disorder, spinal cord disorder, spinal cord injury, spinal stenosis, spondylosis, vertebral column disorder | Recruiting | Phase 1 | 2026-07-10 | NCT06438471 |